Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03662802 · ClinicalTrials.gov registry record
Development of a Novel Convolution Neural Network for Arrhythmia Classification
A clinical trial, sponsored by Scripps Clinic.
- Completed
- Registry status
- 25,458
- Enrollment target
NCT03662802: Completed study, sponsored by Scripps Clinic.
NCT03662802 is a clinical trial that has completed, run by Scripps Clinic. The registered enrollment target is 25,458 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03662802 has completed, sponsored by Scripps Clinic.
- COMPLETED
- Registry status
- 25,458 participants
- Enrollment target
Study Summary
Identifying the correct arrhythmia at the time of a clinic event including cardiac arrest is of high priority to patients, healthcare organizations, and to public health. Recent developments in artificial intelligence and machine learning are providing new opportunities to rapidly and accurately diagnose cardiac arrhythmias and for how new mobile health and cardiac telemetry devices are used in patient care. The current investigation aims to validate a new artificial intelligence statistical approach called 'convolution neural network classifier' and its performance to different arrhythmias diagnosed on 12-lead ECGs and single-lead Holter/event monitoring. These arrhythmias include; atrial fibrillation, supraventricular tachycardia, AV-block, asystole, ventricular tachycardia and ventricular fibrillation, and will be benchmarked to the American Heart Association performance criteria (95% one-sided confidence interval of 67-92% based on arrhythmia type). In order to do so, the study approach is to create a large ECG database of de-identified raw ECG data, and to train the neural network on the ECG data in order to improve the diagnostic accuracy.
Primary Outcome
American Heart Association ECG Performance Criteria
Interventions
- OTHER Neural Network Classifier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,458 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2020-10-01 |
What the finished NCT03662802 record still lists
NCT03662802 is an observational study that tracks outcomes without assigning an intervention. Its 25,458 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Neural Network Classifier is the first listed.
NCT03662802 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03662802 about?
NCT03662802 is a clinical study titled "Development of a Novel Convolution Neural Network for Arrhythmia Classification". Identifying the correct arrhythmia at the time of a clinic event including cardiac arrest is of high priority to patients, healthcare organizations, and to public health. Recent developments in artificial intelligence and machine learning are providing new opportunities to rapidly and accurately dia...
What is the current status of trial NCT03662802?
This trial is currently completed. The enrollment target is 25,458 participants. The study started on 2018-10-01. Estimated completion is 2020-10-01.
What interventions are being tested in trial NCT03662802?
The interventions under investigation include: Neural Network Classifier (OTHER).
Who is sponsoring clinical trial NCT03662802?
This trial is sponsored by Scripps Clinic, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT04994015 · 25,000 participants
Parkinson's Foundation PD GENEration Genetic Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI